A Phase 2 Evaluation of the Safety, Ocular Tolerability, and Efficacy of Topical Ophthalmic BL1107 Versus Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Recruiting
Location: See all (8) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults with Primary Open Angle Glaucoma or Ocular Hypertension
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Ocular hypertension or primary open-angle glaucoma in each eye
Locations
United States
California
Global Research Management, Inc.
RECRUITING
Glendale
Eye Research Foundation
RECRUITING
Newport Beach
Florida
Levenson Eye Associates
NOT_YET_RECRUITING
Jacksonville
Central Florida Eye Associates
NOT_YET_RECRUITING
Lakeland
Lee Shettle Eye and Hearing
RECRUITING
Largo
Massachusetts
Andover Eye Associates
NOT_YET_RECRUITING
Andover
Pennsylvania
Scott & Christie and Associates, PC
NOT_YET_RECRUITING
Cranberry Township
Tennessee
Total Eye Care, P.A.
RECRUITING
Memphis
Contact Information
Primary
Johnson Varughese
Johnson.Varughese@bausch.com
9089271162
Time Frame
Start Date: 2025-10-24
Estimated Completion Date: 2026-05
Participants
Target number of participants: 228
Treatments
Experimental: BL1107 Low dose
Experimental: BL1107 High dose
Active_comparator: Timolol maleate 0.5%
Related Therapeutic Areas
Sponsors
Leads: Bausch & Lomb Incorporated